XOMA News and Press, XOMA Corporation From 08/06/20

XOMA (NASDAQ: XOMA ) : Q2 GAAP EPS of -$0.33 beats by $0.05 . More news on: XOMA Corporation, Earnings news and commentary, Healthcare stocks news, , Read more ...

EMERYVILLE, Calif., Aug. 06, 2020 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA), today announced its second quarter 2020 royalty asset portfolio advancements and financial results.  “With a healthy cash position, a low-cost infrastructure, and a strict discipline on cap...

EMERYVILLE, Calif., Aug. 05, 2020 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA) announced today its Chief Executive Officer, Jim Neal, will present a Company business update at the Wedbush PacGrow Virtual Healthcare Conference 2020. The presentation will take place on Wednesday, Au...

Co-produced with Trapping Value Natural Gas ( UNG ). The commodity that's known as the widow maker in the trading pits. With ultra-high volatility and a passion for doing the unexpected, it has created lots of millionaires (assuming they started off as billionaires). We are loathe to...

EMERYVILLE, Calif., July 01, 2020 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA) announced today Natasha A. Hernday, Senior Vice President, Corporate Development at Seattle Genetics, Inc., has joined the Company’s Board of Directors.  Ms. Hernday has 20 years of experience ...

EMERYVILLE, Calif., June 29, 2020 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) today announced the Company has been added to the Russell 2000 ® and Russell 3000 ® Indexes following the annual reconstitution, which took effect after the U.S. market closed on June 26, 2020....

XOMA (NASDAQ: XOMA ): Q1 GAAP EPS of -$0.49 misses by $0.33 . More news on: XOMA Corporation, Earnings news and commentary, Healthcare stocks news, , Read more ...

EMERYVILLE, Calif., May 05, 2020 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) reported its first quarter 2020 financial results and provided a COVID-19 business update. “Our first priority is to ensure the safety and well-being of our employees, our consultants, and our par...

Intro & pipeline Agenus ( AGEN ) is an immuno-oncology ((IO)) company with a deep and diversified pipeline, a technology for novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing. Agenus believes that the...

XOMA (NASDAQ: XOMA ): Q4 GAAP EPS of -$0.49 misses by $0.21 . More news on: XOMA Corporation, Earnings news and commentary, Healthcare stocks news, , Read more ...